Lino-Silva LS, Salcedo-Hernández RA

Language: Spanish
References: 15
Page: 432-436
PDF size: 231.71 Kb.

ABSTRACT

Micropapillary carcinoma is regarded as an aggressive variant of adenocarcinoma in any location. It is histologically characterized by papillary cell clusters surrounded by clear spaces. The reported proportion of micropapillary carcinoma component in the entire tumor ranges from 5-80% and no pure cases have been reported. To date, there are approximately 130 cases reported in the colorectum. We recently examined a patient with a pure micropapillary carcinoma showing co-expression of CK7, CK20, and absence of CDX2, which had an aggressive tumor with extensive perineural, vascular, and lymphatic invasion as well as extensive nodal metastasis. The presence of a micropapillary carcinoma in the colorectum seemed to be closely related with nodal metastasis, as observed in micropapillary carcinomas from other organs. Thus, if a micropapillary component is identified in a tumor, particularly in a biopsy specimen, extensive surgical resection should be considered due to the high potential for nodal metastasis, even if the preoperative diagnosis is a pedunculated early colorectal cancer.

REFERENCES

1. Verdú M, Román R, Calvo M, et al. Clinicopathologicaland molecular characterizationofcolorectalmicropapillary carcinoma. ModPathol. 2011;24(5):729-38.

2. Amin MB, Ro JY, El-Sharkawy T, et al Micropapillaryvariantoftransitionalcell carcinoma oftheurinarybladder. Histologicpatternresemblingovarianpapillary carcinoma. Am J SurgPathol. 1994;18:1224-32.

3. Nassar H. Carcinomas withmicropapillarymorphology: clinicalsignificanceandcurrentconcepts. AdvAnatPathol. 2004;11:297-303.

4. SaadRS, Silverman JF, Khalifa MA, Roswell C. CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal adenocarcinoma. ApplImmunohistochem Mol Morphol. 2009;17:196-201.

5. Hernández BY, Frierson HF, MoskalukCA, et al. CK20 and CK7 proteinexpression in colorectalcancer: demonstrationoftheutilityof a populationbasedtissuemicroarray. HumPathol. 2005;36:275-81.

6. Choi BJ, Kim CJ, Cho YG, et al. Alteredexpressionof CDX2 in colorectalcancers. APMIS. 2006;114(1):50-4.

7. Baba Y, Nosho K, Shima K, et al.Relationshipof CDX2 losswith molecular featuresand prognosis in colorectalcancer. ClinCancer Res. 2009;15(14):4665-73.

8. Haupt B, Ro JY, SchwartzMR, Shen SS. Colorectal adenocarcinoma withmicropapillarypatternanditsassociationwithlymphnodemetastasis. ModPathol. 2007;20:729-33.

9. Kim MJ, Hong SM, Jang SJ, et al. Invasivecolorectalmicropapillary carcinoma: anaggressivevariantof adenocarcinoma. HumPathol. 2006;37:809-15.

10. Kuroda N, Oonishi K, Ohara M, et al. Invasivemicropapillary carcinoma ofthe colon: animmunohistochemicalstudy. Med Mol Morphol 2007;40: 226–230.

11. Sakamoto K, Watanabe M, De La Cruz C, Honda H, Ise H, Mitsui K et al. Primaryinvasivemicropapillary carcinoma ofthe colon. Histopathology. 2005;47:479-84.

12. Wen P, Xu Y, FrankelWL, Shen R. Invasivemicropapillary carcinoma ofthesigmoid colon: distinctmorphologyandaggressivebehavior. Int J ClinExpPathol. 2008;1:457-60.

13. Xu F, Xu J, Lou Z, et al. Micropapillarycomponent in colorectal carcinoma isassociatedwithlymphnodemetastases in T1 andT2stagesanddecreasedsurvival time in TNMstages I and II. Am J SurgPathol. 2009; 33:1287-92.

14. Sonoo H, Kameyama M, Inatugi N, Nonomura A, Enomoto Y. Pedunculatedpolypofearlysigmoid colon cancerwithinvasivemicropapillary carcinoma. Jpn J Clin Oncol. 2009;38(8):523-7.

15. Lotan TL, Ye H, Melamed J, Wu XR, ShihIE, Epstein JE. Immunohistochemicalpanel toidentifytheprimarysiteofinvasivemicropapillary carcinoma. Am J SurgPathol. 2009;33:1037-41.